4,4',5,5'-TETRAHYDROXY-2,2'-DIMETHOXY-7,7'-DIMETHYL(9,9'-BIANTHRACENE)-10,10'(9H,9'H)-DIONE, TRANS-
UNII 3ASD7PR32A

Substance Identification & Data

This profile provides standardized clinical and technical data for 4,4',5,5'-tetrahydroxy-2,2'-dimethoxy-7,7'-dimethyl(9,9'-bianthracene)-10,10'(9h,9'h)-dione, Trans-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3ASD7PR32A.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1658479-86-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
3ASD7PR32A
CAS Registry Number
1658479-86-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
4,4',5,5'-TETRAHYDROXY-2,2'-DIMETHOXY-7,7'-DIMETHYL(9,9'-BIANTHRACENE)-10,10'(9H,9'H)-DIONE, TRANS-
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C32H26O8
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
CZJNLQOXUCEPOH-CLJLJLNGSA-N
Line notation for describing the chemical structure and connectivity of atoms.
Substance Type
4,4?,5,5?-Tetrahydroxy-2,2?-dimethoxy-7,7?-dimethyl[9,9?-bianthracene]-10,10?(9H,9?H)-dione, trans-
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
O=C1c2c([C@@](c3c1c(O)cc(C)c3)([C@]4(c5c(C(=O)c6c4cc(C)cc6O)c(O)cc(OC)c5)[H])[H])cc(OC)cc2O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 4,4',5,5'-tetrahydroxy-2,2'-dimethoxy-7,7'-dimethyl(9,9'-bianthracene)-10,10'(9h,9'h)-dione, Trans-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

4,4′,5,5′-Tetrahydroxy-2,2′-dimethoxy-7,7′-dimethyl[9,9′-bianthracene]-10,10′(9H,9′H)-dione, trans-
trans-4,4′,5,5′-Tetrahydroxy-2,2′-dimethoxy-7,7′-dimethyl[9,9′-bianthracene]-10,10′(9H,9′H)-dione

Systematic Nomenclature

4,4′,5,5′-Tetrahydroxy-2,2′-dimethoxy-7,7′-dimethyl[9,9′-bianthracene]-10,10′(9H,9′H)-dione, rel-(9R,9′R)-
[9,9′-Bianthracene]-10,10′(9H,9′H)-dione, 4,4′,5,5′-tetrahydroxy-2,2′-dimethoxy-7,7′-dimethyl-, (9R,9′R)-rel-
rel-(9R,9′R)-4,4′,5,5′-Tetrahydroxy-2,2′-dimethoxy-7,7′-dimethyl[9,9′-bianthracene]-10,10′(9H,9′H)-dione

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record